LHCSX Performance — Lord Abbett Health Care Fund, Class R4
Data updated: 2026-09-25
LHCSX returned +3.17% year to date and +28.68% over one year to Jul 2026. Annualised returns are +9.02% over 3 years and +3.57% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $130, against $137 for the category, and to $129 over one year, against $137. Volatility over the past three years was 16.69% a year. In the 12 months to Jul 2026 the fund lost a net $610K, and assets reached $8.56M.
LHCSX Growth of $100
What $100 invested in Lord Abbett Health Care Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | LHCSX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $129 | $137 |
| 3 years (Aug 2023 – Jul 2026) | $130 | $137 |
| 5 years (Aug 2021 – Jul 2026) | $119 | $121 |
| Since data start (Aug 2019 – Jul 2026) | $189 | $183 |
LHCSX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.17% |
| 1 year | +28.68% |
| 3 years (annualised) | +9.02% |
| 5 years (annualised) | +3.57% |
LHCSX Annual Returns
Calendar-year total returns of Lord Abbett Health Care Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +3.17% |
| 2025 | +17.70% |
| 2024 | +7.24% |
| 2023 | +3.00% |
| 2022 | −12.04% |
| 2021 | +8.18% |
| 2020 | +37.13% |
| 2019 (Aug–Dec) | +7.93% |
LHCSX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.3% | +0.9% | −4.6% | +0.2% | +2.3% | +7.3% | −1.2% | — | — | — | — | — |
| 2025 | +5.0% | −2.9% | −6.9% | +1.1% | −3.3% | +4.0% | −2.3% | +8.0% | +2.4% | +7.3% | +9.7% | −4.1% |
| 2024 | +1.4% | +4.6% | +2.3% | −5.3% | +3.0% | +3.0% | +0.6% | +5.7% | −2.6% | −2.1% | +4.7% | −7.2% |
| 2023 | +0.9% | −3.1% | +1.0% | +5.9% | −2.0% | +2.0% | −1.0% | −2.4% | −6.3% | −6.4% | +7.1% | +8.7% |
| 2022 | −12.3% | +0.9% | +4.3% | −7.8% | −1.3% | −0.8% | +5.3% | −2.7% | −5.1% | +6.6% | +4.0% | −2.0% |
| 2021 | +2.7% | −0.6% | −3.8% | +4.9% | −3.1% | +5.5% | +1.7% | +4.1% | −5.2% | +5.6% | −8.1% | +5.5% |
| 2020 | −1.6% | −4.3% | −5.8% | +12.1% | +7.9% | +0.4% | +4.3% | +4.0% | +3.0% | −1.0% | +8.5% | +6.2% |
| 2019 | — | — | — | — | — | — | — | −2.4% | −4.8% | +3.9% | +8.5% | +3.1% |
LHCSX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 16.69%
- 3-year Sharpe ratio: 0.27 (vs 4.5% risk-free rate)
- Best month: +9.71% (Nov 2025)
- Worst month: −7.22% (Dec 2024)
LHCSX Fund Flows
Monthly money in and out of Lord Abbett Health Care Fund, from SEC Form N-PORT.
- 12-month net flow: −$610K
- 12-month gross sales (incl. reinvestments): $322K
- Sales ÷ redemptions: 0.35×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $48K | $44K | $4K |
| Jun 2026 | $14K | $83K | −$70K |
| May 2026 | $6K | $189K | −$182K |
| Apr 2026 | $10K | $57K | −$47K |
| Mar 2026 | $18K | $54K | −$36K |
| Feb 2026 | $17K | $183K | −$166K |
| Jan 2026 | $33K | $81K | −$48K |
| Dec 2025 | $37K | $60K | −$23K |
| Nov 2025 | $37K | $24K | $13K |
| Oct 2025 | $52K | $35K | $17K |
| Sep 2025 | $36K | $21K | $15K |
| Aug 2025 | $15K | $102K | −$87K |
LHCSX Assets Under Management
Net assets of Lord Abbett Health Care Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $8.56M |
| 2026-04-30 | $8.15M |
| 2026-01-31 | $8.70M |
| 2025-10-31 | $8.45M |
| 2025-07-31 | $7.18M |
| 2025-04-30 | $7.51M |
| 2025-01-31 | $8.67M |
| 2024-10-31 | $8.56M |
| 2024-07-31 | $8.53M |
| 2024-04-30 | $8.15M |
| 2024-01-31 | $8.28M |
| 2023-10-31 | $6.98M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.